University Hospital in Krakow
University Hospital in Krakow
Polonia, Cracovia
| Polonia | Turchia | Austria | |
| Terapia con protoni | da $85,000 | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | da $12,000 | da $9,500 | da $22,000 |
| Resezione gastrica | da $10,000 | da $16,470 | da $22,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $8,000 | da $3,300 | da $15,000 |
| Gastroectomia | da $8,000 | da $18,300 | da $25,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro gastrico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro gastrico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro gastrico.
Il medico è un oncologo altamente esperto con un focus su trattamenti innovativi per il cancro e cure personalizzate per i pazienti. Con oltre 15 anni nel campo, il medico ha contribuito significativamente ai progressi nella chemioterapia e nell'immunoterapia. Il medico è certificato dal consiglio in oncologia e ha pubblicato numerosi articoli di ricerca su riviste mediche di primo piano. Inoltre, il medico ha partecipato a diversi studi clinici mirati a migliorare i tassi di sopravvivenza al cancro.<\/p>
Stomach cancer treatment in Poland shows a 5-year survival rate of approximately 26%. Success varies significantly by stage. Early-stage cases treated with surgery reach survival rates up to 70%. Complete tumor removal (R0 resection) leads to a 43.5% 5-year survival rate.
Bookimed Expert Insight: While overall survival averages 26%, the University Hospital in Krakow manages 455,000 patients annually. This high volume is a key quality indicator. Centers with this capacity often utilize the Da Vinci Robotic System. Expert surgeons like Dr. Andrzej Wronski emphasize that high-volume centers typically achieve better surgical margins.
Patient Consensus: Patients note that early detection dramatically shifts outcomes. They emphasize checking a surgeon's gastrectomy volume and seeking nutritional support for post-surgery recovery.
Advanced robotic treatments for stomach cancer are available in Poland at specialized oncology centers and large academic hospitals. Facilities utilize systems like the da Vinci robotic platform to perform precise gastric resections. These procedures offer reduced trauma, less blood loss, and faster recovery compared to traditional open surgery.
Bookimed Expert Insight: While robotic surgery is advancing, Poland stands out for its specialized academic centers. University Hospital in Krakow alone treats 455,000 patients annually across 103 departments. This massive patient volume suggests that surgeons at such institutions gain significant experience in complex cases. When considering robotic options, prioritize these high-volume centers where surgeons maintain peak technical proficiency through frequent procedures.
Patient Consensus: Patients note that while robotic technology is emerging, the standard of care remains highly effective with laparoscopic techniques. Many emphasize that the surgeon's hands-on experience matters more than the specific machine used for the resection.
The best hospitals for stomach cancer in Poland include the University Hospital in Krakow and the European Health Center Otwock. These facilities provide advanced stomach resection, HIPEC, and robotic-assisted gastrectomy. They utilize multidisciplinary tumor boards and specialized cardio-oncology departments to manage complex cases.
Bookimed Expert Insight: While prestige matters, volume is the strongest indicator of success for gastric procedures. The University Hospital in Krakow stands out with over 1,000 doctors and 1,600 beds. This massive scale often correlates with surgeons like Dr. Andrzej Wronski maintaining higher procedural frequencies. For stomach cancer, centers with these high volumes typically report 85% efficacy for early-stage surgical interventions.
Patient Consensus: Patients emphasize the importance of neoadjuvant chemotherapy protocols and confirm that having a single team manage all treatment phases reduces delays. Many survivors recommend requesting written staging and pathology reports in plain language before scheduling surgery.